WPG Advisers
ANGO icon

WPG Advisers’s AngioDynamics ANGO Stock Holding History

WPG Advisers’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$369 Buy
+24
New +$358 ﹤0.01% 1498

Other funds holding ANGO

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Weber Capital Management
Weber Capital Management San Francisco, California $110M AUM 43.35% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Pier Capital
Pier Capital Stamford, Connecticut $690M AUM 65.51% 1-Year Est. Return

WPG Advisers's ANGO Position: Q3 2026 in Review

WPG Advisers opened a new position in AngioDynamics (ANGO) in Q3 2026: 24 shares worth $369. The stake represents ﹤0.01% of the portfolio and ranks #1498 among its holdings.

122 funds tracked by Wall St. Rank hold ANGO as of Q3 2026.

  • WPG Advisers held 24 shares of AngioDynamics worth $369 as of Q3 2026.
  • AngioDynamics was a new WPG Advisers position in Q3 2026.
  • AngioDynamics made up ﹤0.01% of WPG Advisers's portfolio in Q3 2026, its #1498 holding.
  • 122 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2026.

Based on WPG Advisers's 13F filing for Q3 2026, filed 27 Oct 2026.